Sevura Inhaler contains the active component Sevoflurane. It is used to produce a complete loss of sensation in the body, including unconsciousness, so that surgical operations or other procedures can be performed. This allows surgery to be carried out without pain or distress.  This medication is used in the hospital environment only and has a quick induction and emergence time. This helps in efficiently managing the anesthesia process. It can be easily adjusted and titrated to maintain the desired level of sedation throughout the procedure. Sevura Inhaler is suitable for many patients, including pediatric and elderly populations. It can be safely used in various surgical procedures and with other anesthetic agents and adjuncts. Individuals with known hypersensitivity or allergy to Sevura Inhaler or other halogenated ethers should not receive this anesthesia. Like other volatile anesthetics, it can trigger malignant hyperthermia, a rare but potentially life-threatening condition characterized by a severe reaction to certain medications used during general anesthesia. Patients with a personal or family history of MH or suspected susceptibility to MH should avoid Sevura Inhaler. Although it is primarily eliminated through exhalation, caution should be exercised in patients with severe renal impairment. Patients with certain pre-existing cardiac conditions, such as severe cardiovascular disease or unstable angina, may require caution when using this medication.